Messenger RNA (mRNA) vaccine development for preventive and therapeutic applications
has evolved rapidly over the last decade. The mRVNA vaccine has proven therapeutic …

mRNA vaccines have evolved as promising cancer therapies. These vaccines can encode
tumor-allied antigens, thus enabling personalized treatment approaches. They can also …

Lung cancer demands innovative approaches for early detection and targeted treatment. In
addressing this urgent need, exosomes play a pivotal role in revolutionizing both the early …

Cancers are increasing in prevalence and many challenges remain for their treatment, such
as chemoresistance and toxicity. In this context, siRNA-based therapeutics have many …

Nanotechnology has emerged as a transformative pathway in vaccine research and
delivery. Nanovaccines, encompassing lipid and nonlipid formulations, exhibit considerable …

This study presents the synthesis of glucosamine-modified mesoporous silica-coated
magnetic nanoparticles (MNPs) as a therapeutic platform for the delivery of an anticancer …

Chimeric antigen receptor (CAR)-T cell therapies have revolutionized cancer treatment,
particularly in hematological malignancies. However, their application to solid tumors is …

In recent years, lipid nanoparticles (LNPs) have attracted extensive attention in tumor
immunotherapy. Targeting immune cells in cancer therapy has become a strategy of great …

Nucleic acid-based therapeutics are a common approach that is increasingly popular for a
wide spectrum of diseases. Lipid nanoparticles (LNPs) are promising delivery carriers that …

The rapid advancement of nanotechnology in recent years has opened new avenues of
investigation for biomedical sciences. Viral nanoparticles (VNPs) are formulated from plant …